18011627651
Company profile
Chengdu Hawk Bio-Engineering Co., Ltd. was created in 1989. In order to meet the needs of the company's continuous development, Sichuan New Hawk Biotechnology Co., Ltd. was established in Sichuan Biomedicine Industrial Park in 2011. The successful establishment of New Hawk has effectively guaranteed our continuous supply capacity. The company has strong production capacity, which can achieve an annual output of more than 1,000 tons of APIs. It has a standard GMP production workshop, a complete quality system, and an independent analysis and testing center and product development center.
Contact Us
30+
Historical experience
10+
Sales area (Overseas)
1,000+
Annual output of raw materials(tons)
WE ARE WORLDWIDE
Hawk-Bio has a history of 36 years and has been committed to the research and development and production of raw materials, especially citrus products. Its products are exported to more than 10 countries and regions including Europe, South America, and Southeast Asia, and are deeply trusted and well received by customers. The company has experienced pharmaceutical experts and technical teams and its own R&D center. It has obtained more than ten national invention patents and utility model patents and is the international business standard audit unit for Hesperidin.

0102030405060708091011121314
● Obtained the import license of APIs issued by the Russian Ministry of Health in 2006.
● Completed the registration of APIs in Brazil ANVISA in 2009.
Appraised as a safety production standardization enterprise in 2013.
● Named as a pilot enterprise for Intellectual Property Rights in Sichuan Province in 2013.
● Rated as a pilot enterprise for Intellectual Property Rights in Sichuan Province in 2013.
● Obtained EDQM's CEP Certificate in 2017.
● Completed the registration of APIs at the Drug Evaluation Center of the National Drug Administration in 2018.
● Obtained the Drug Production License in 2020.
● Won the National High-tech Enterprise in 2021.
● Obtained the EcoVadis Bronze Medal for Sustainable Development in 2023.
● Obtained the EU API Export Certification Document (WC) in 2024.
● Completed the registration of APIs in Brazil ANVISA in 2009.
Appraised as a safety production standardization enterprise in 2013.
● Named as a pilot enterprise for Intellectual Property Rights in Sichuan Province in 2013.
● Rated as a pilot enterprise for Intellectual Property Rights in Sichuan Province in 2013.
● Obtained EDQM's CEP Certificate in 2017.
● Completed the registration of APIs at the Drug Evaluation Center of the National Drug Administration in 2018.
● Obtained the Drug Production License in 2020.
● Won the National High-tech Enterprise in 2021.
● Obtained the EcoVadis Bronze Medal for Sustainable Development in 2023.
● Obtained the EU API Export Certification Document (WC) in 2024.
01
010203
The innovation progress of Hawk Bio. is pushing us towards a more sustainable future. We are actively responding to the United Nations Sustainable Development Goals and Climate Action. By the end of June 2024, the plant had installed the first phase of solar photovoltaic panels with a power generation capacity of 200KW, which can meet 60% of the electricity demand of the whole factory. After the completion of the second phase of the project, solar power generation will meet all the electricity demand of the whole factory.


























